Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Shimizu

Showing results (71-80 of 207) with videos related to

Pageof 21
Sort By:
The Journal of International Medical Research|June 11, 2019
A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancerTetsuo Shimizu, Yoshiko Nakagawa, Yasuo Asai, et al.
Community Mental Health Journal|May 7, 2011
Prevalence of psychological distress, as measured by the Kessler 6 (K6), and related factors in Japanese employeesMasahito Fushimi, Seiji Saito, Tetsuo Shimizu, et al.
Neuropsychobiology|November 11, 2010
Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trialYuichi Inoue, Kenji Kuroda, Koichi Hirata, et al.
Thoracic Cancer|November 4, 2016
Lung squamous cell carcinoma with brachial soft tissue metastasis responsive to gefitinib: Report of a rare caseKana Kataoka, Eiji Osaka, Tetsuo Shimizu, et al.
Ryoikibetsu Shokogun Shirizu|September 25, 2003
[Idiopathic hypersomnia]Takashi Kanbayashi, Yuriko Ogawa, Masato Abe, et al.
Human Psychopharmacology|August 11, 2004
Milnacipran treatment of a terminally ill cancer patient with major depressive disorderKazuhiro Sato, Hisashi Higuchi, Keizo Yoshida, et al.
Thoracic Cancer|November 29, 2019
Successful treatment of an elderly patient with an uncommon L861Q epidermal growth factor receptor mutation with low-dose afatinib: A case reportYuko Iida, Fumio Kumasawa, Tetsuo Shimizu, et al.
Clinical Neuropharmacology|October 2, 2003
Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reportsHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
Neuroscience Letters|July 13, 2004
Similar profiles in human period1 gene expression in peripheral mononuclear and polymorphonuclear cellsHiroaki Kusanagi, Kazuo Mishima, Kohtoku Satoh, et al.
Human Psychopharmacology|June 15, 2007
Dissociation between objective psychomotor impairment and subjective sleepiness after diazepam administration in the aged peopleMasaru Echizenya, Kazuo Mishima, Kohtoku Satoh, et al.
Pageof 21

Showing results (71-80 of 207) with videos related to

Sort By:
Pageof 21
The Journal of International Medical Research|June 11, 2019
A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancerTetsuo Shimizu, Yoshiko Nakagawa, Yasuo Asai, et al.
Community Mental Health Journal|May 7, 2011
Prevalence of psychological distress, as measured by the Kessler 6 (K6), and related factors in Japanese employeesMasahito Fushimi, Seiji Saito, Tetsuo Shimizu, et al.
Neuropsychobiology|November 11, 2010
Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trialYuichi Inoue, Kenji Kuroda, Koichi Hirata, et al.
Thoracic Cancer|November 4, 2016
Lung squamous cell carcinoma with brachial soft tissue metastasis responsive to gefitinib: Report of a rare caseKana Kataoka, Eiji Osaka, Tetsuo Shimizu, et al.
Ryoikibetsu Shokogun Shirizu|September 25, 2003
[Idiopathic hypersomnia]Takashi Kanbayashi, Yuriko Ogawa, Masato Abe, et al.
Human Psychopharmacology|August 11, 2004
Milnacipran treatment of a terminally ill cancer patient with major depressive disorderKazuhiro Sato, Hisashi Higuchi, Keizo Yoshida, et al.
Thoracic Cancer|November 29, 2019
Successful treatment of an elderly patient with an uncommon L861Q epidermal growth factor receptor mutation with low-dose afatinib: A case reportYuko Iida, Fumio Kumasawa, Tetsuo Shimizu, et al.
Clinical Neuropharmacology|October 2, 2003
Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reportsHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
Neuroscience Letters|July 13, 2004
Similar profiles in human period1 gene expression in peripheral mononuclear and polymorphonuclear cellsHiroaki Kusanagi, Kazuo Mishima, Kohtoku Satoh, et al.
Human Psychopharmacology|June 15, 2007
Dissociation between objective psychomotor impairment and subjective sleepiness after diazepam administration in the aged peopleMasaru Echizenya, Kazuo Mishima, Kohtoku Satoh, et al.
Pageof 21